Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice

Little observational data exist describing telbivudine (LdT) or lamivudine (LAM) use in late pregnancy for preventing hepatitis B mother-to-child transmission (MTCT) in real-world settings. During the period of January 2009 to March 2011, we enrolled hepatitis B e antigen–positive mothers with HBV D...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Hepatology
Asıl Yazarlar: Zhang, Hua, Pan, Calvin Q, Pang, Qiumei, Tian, Ruihua, Yan, Miaoe, Liu, Xin
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BlackWell Publishing Ltd 2014
Konular:
Viral Hepatitis
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4282428/
https://ncbi.nlm.nih.gov/pubmed/25187919
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.27034
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller